PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34524633-10	2021	On the other hand, OXA-23-like isolates were more sensitive to the combination of tigecycline and colistin.	Tigecycline	82-93	class D beta-lactamase OXA-23	Acinetobacter baumannii	19-25	
31168197-6	2018	Using the EUCAST criteria, the rate of resistance to tigecycline for the OXA-23 MBL-positive, OXA-23 MBL-negative and carbapenemase-negative strains for BMM was 54.5% (6/11), 29.4% (5/17) and 2.7% (1/37), respectively; the OXA-24/40 and OXA-58 producing organisms did not exhibit any resistance.	Tigecycline	53-64	class D beta-lactamase OXA-23	Acinetobacter baumannii	73-79	
31168197-6	2018	Using the EUCAST criteria, the rate of resistance to tigecycline for the OXA-23 MBL-positive, OXA-23 MBL-negative and carbapenemase-negative strains for BMM was 54.5% (6/11), 29.4% (5/17) and 2.7% (1/37), respectively; the OXA-24/40 and OXA-58 producing organisms did not exhibit any resistance.	Tigecycline	53-64	class D beta-lactamase OXA-23	Acinetobacter baumannii	94-100	
24328852-2	2014	These multidrug-resistant isolates, which belonged to a single clone, remained only susceptible to tigecycline, minocycline, and colistin and produced the carbapenem-hydrolyzing oxacillinase, OXA-23.	Tigecycline	99-110	class D beta-lactamase OXA-23	Acinetobacter baumannii	192-198	
28081345-0	2016	Growing OXA-23 type strains among carbapenem-resistant Acinetobacter baumannii and tigecycline as an alternate combination therapy.	Tigecycline	83-94	class D beta-lactamase OXA-23	Acinetobacter baumannii	8-14